Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251026778> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4251026778 abstract "Aim of the study: Hydrocortisone is a soft steroid with low anti-inflammatory properties and a short duration of action, used to manage several ocular conditions. The clinical benefits and side effects associated with hydrocortisone are well documented, but its basic pharmacokinetic in the eye is yet to be fully elucidated. The purpose of this study is to investigate the anterior chamber penetration capabilities of hydrocortisone when used in different concentrations as eye drops treatment. Materials and Methods: This is a double-blind, single-center, randomized clinical trial performed at the Department of Medicine and Surgery of the University of Perugia (Italy) on consecutive patients who have undergone phacoemulsification with intraocular lens implantation. Patients were randomly assigned on the morning of surgery to receive a single instillation of 0.33% (group A) or 0.001% (group B) hydrocortisone sodium phosphate solution. Group of patients C did not receive any treatment and was used to measure the hydrocortisone endogenous levels. Before surgery, one aliquot of aqueous humor for each patient was aspirated. The time of collection for each sample was recorded. Hydrocortisone concentrations were then stratified into six interval classes of 30 minutes each. Results: The mean concentration of hydrocortisone was significantly higher in group A (25.2±12.4 ng/ml) compared with group B (7.11±1.51 ng/ml) and compared to the mean hydrocortisone endogenous levels (3.92±1.18 ng/ml) (p<0.0001). No statistically significant differences of hydrocortisone mean concentrations between group B and the mean endogenous levels were found. Conclusions: Considering the frequent need for prolonged topical steroid therapies and the possible consequent undesirable side effects, ophthalmologists should consider the lowest clinically effective dose of hydrocortisone useful to obtain the desired therapeutic effect and in an adequate time, to minimize the amount of steroids into the anterior chamber and to avoid side effects, such as intraocular pressure increase or cataract development." @default.
- W4251026778 created "2022-05-12" @default.
- W4251026778 creator A5006127932 @default.
- W4251026778 creator A5024018059 @default.
- W4251026778 creator A5061095199 @default.
- W4251026778 creator A5066821371 @default.
- W4251026778 creator A5082675698 @default.
- W4251026778 creator A5087779324 @default.
- W4251026778 creator A5089776690 @default.
- W4251026778 date "2021-08-10" @default.
- W4251026778 modified "2023-09-28" @default.
- W4251026778 title "Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application" @default.
- W4251026778 doi "https://doi.org/10.22541/au.162857523.38379921/v1" @default.
- W4251026778 hasPublicationYear "2021" @default.
- W4251026778 type Work @default.
- W4251026778 citedByCount "0" @default.
- W4251026778 crossrefType "posted-content" @default.
- W4251026778 hasAuthorship W4251026778A5006127932 @default.
- W4251026778 hasAuthorship W4251026778A5024018059 @default.
- W4251026778 hasAuthorship W4251026778A5061095199 @default.
- W4251026778 hasAuthorship W4251026778A5066821371 @default.
- W4251026778 hasAuthorship W4251026778A5082675698 @default.
- W4251026778 hasAuthorship W4251026778A5087779324 @default.
- W4251026778 hasAuthorship W4251026778A5089776690 @default.
- W4251026778 hasBestOaLocation W42510267781 @default.
- W4251026778 hasConcept C112705442 @default.
- W4251026778 hasConcept C118487528 @default.
- W4251026778 hasConcept C126322002 @default.
- W4251026778 hasConcept C126894567 @default.
- W4251026778 hasConcept C141071460 @default.
- W4251026778 hasConcept C16613235 @default.
- W4251026778 hasConcept C185592680 @default.
- W4251026778 hasConcept C2776804153 @default.
- W4251026778 hasConcept C2778257484 @default.
- W4251026778 hasConcept C2778709874 @default.
- W4251026778 hasConcept C2778744145 @default.
- W4251026778 hasConcept C2781104129 @default.
- W4251026778 hasConcept C2993390227 @default.
- W4251026778 hasConcept C42219234 @default.
- W4251026778 hasConcept C71924100 @default.
- W4251026778 hasConcept C90924648 @default.
- W4251026778 hasConceptScore W4251026778C112705442 @default.
- W4251026778 hasConceptScore W4251026778C118487528 @default.
- W4251026778 hasConceptScore W4251026778C126322002 @default.
- W4251026778 hasConceptScore W4251026778C126894567 @default.
- W4251026778 hasConceptScore W4251026778C141071460 @default.
- W4251026778 hasConceptScore W4251026778C16613235 @default.
- W4251026778 hasConceptScore W4251026778C185592680 @default.
- W4251026778 hasConceptScore W4251026778C2776804153 @default.
- W4251026778 hasConceptScore W4251026778C2778257484 @default.
- W4251026778 hasConceptScore W4251026778C2778709874 @default.
- W4251026778 hasConceptScore W4251026778C2778744145 @default.
- W4251026778 hasConceptScore W4251026778C2781104129 @default.
- W4251026778 hasConceptScore W4251026778C2993390227 @default.
- W4251026778 hasConceptScore W4251026778C42219234 @default.
- W4251026778 hasConceptScore W4251026778C71924100 @default.
- W4251026778 hasConceptScore W4251026778C90924648 @default.
- W4251026778 hasLocation W42510267781 @default.
- W4251026778 hasOpenAccess W4251026778 @default.
- W4251026778 hasPrimaryLocation W42510267781 @default.
- W4251026778 hasRelatedWork W1986710366 @default.
- W4251026778 hasRelatedWork W2022336279 @default.
- W4251026778 hasRelatedWork W2066225521 @default.
- W4251026778 hasRelatedWork W2394033013 @default.
- W4251026778 hasRelatedWork W2397297786 @default.
- W4251026778 hasRelatedWork W2416146248 @default.
- W4251026778 hasRelatedWork W2428850940 @default.
- W4251026778 hasRelatedWork W3205862771 @default.
- W4251026778 hasRelatedWork W4249189119 @default.
- W4251026778 hasRelatedWork W4251026778 @default.
- W4251026778 isParatext "false" @default.
- W4251026778 isRetracted "false" @default.
- W4251026778 workType "article" @default.